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ABSTRACT: Miniaturization and acceleration of synthetic
chemistry are critically important for rapid property optimiza-
tion in pharmaceutical, agrochemical, and materials research and
development. However, in most laboratories organic synthesis is
still performed on a slow, sequential, and material-consuming
scale and not validated for multiple substrate combinations.
Herein, we introduce fast and touchless acoustic droplet ejection
(ADE) technology into small-molecule chemistry to transfer
building blocks by nL droplets and to scout a newly designed
isoquinoline synthesis. With each compound in a discrete well,
384 random derivatives were synthesized in an automated fashion, and their quality was monitored by SFC-MS and TLC-UV-
MS analysis. We exemplify a pipeline of fast and eﬃcient nmol scouting to mmol- and mol-scale synthesis for the discovery of a
useful novel reaction with great scope.
New materials and drugs are discovered by sequentialoptimization of properties involving the synthesis and
testing of many diﬀerent chemicals. There is an urgent need for
acceleration and miniaturization of synthetic organic chemistry
in the quest for new synthetic methodologies.1−4 New library
design in the pharmaceutical industry intends to overcome the
monotonous use of a few validated robust organic reactions.5−7
The overuse of the 20 most popular reactions in medicinal
chemistry leads to a limited, crowded, and narrow chemistry
space.8 However, new synthetic methodologies result in
making and exploring structures that were previously
inaccessible.9,10 Commercial availability of reagents, high
robustness of the reactions, and a pressure on delivery were
proposed as reasons for the overuse of some handful of
reactions, while many new synthetic methodologies are
neglected.11 Often reaction discovery and optimization are
done in a sequential fashion, and scope and limitations are not
elaborated; however, rather simple derivatives with high yields
are presented in the initial report of novel synthetic
methodologies. “Real-world” syntheses involving more com-
plex building blocks then often disappointingly show severe
limitations in substrate scope. Therefore, miniaturization,
automation, and resulting acceleration of synthetic chemistry
is an emerging ﬁeld.12−17 Recent applications of high-
throughput experimentation (HTE) in synthetic chemistry
included the scope and limitation and catalyst optimization of
well-known two-component C−C, C−N, and C−O cou-
plings.18,19 Established methods of miniaturized synthesis
include ﬂow-chemistry20−23 and positive displacement liquid
handling.24,25 Here, we introduce for the ﬁrst time acoustic
droplet injection (ADE) for the fast and touchless nL-volume
transfer of reagents to probe a new isoquinoline synthesis for
the synthesis of a large number of discrete and novel
compounds in a short time. In ADE, short and precise
acoustic waves are applied to a liquid, and very small
nanodroplets of deﬁned size are ejected and transported to a
destination.26 Speciﬁc advantages of ADE over other micro-
ﬂuidic or positive displacement liquid handling technologies
include very low droplet volumes of 2.5 nL, very high accuracy,
unprecedented fast reagent transfer (∼200 Hz) leading to the
fast reagent pipetting for combinatorial as well as random
libraries, and eliminating any sources of cross-contamination.27
Our design is based on the combination of the Ugi four-
component reaction,28 the Pomeranz−Fritsch reaction,29,30
and the Schlittler−Müller modiﬁcation31,32 to potentially pave
an attractive novel pathway to synthesize diverse isoquinolines.
We envisioned broadly accessing substituted isoquinolines and
heterocyclic derivatives by the use of the bifunctional
monoprotected 2,2-dimethoxy acetaldehyde as a key compo-
nent in the Ugi reaction followed by an acid hydrolysis and
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spontaneous oxidation step (Figure 1G). Unlike the classical
multistep sequential isoquinoline syntheses, variation on the
phenyl and the amide part could be performed at the same
time in a one-pot fashion. Thus, a much greater chemical space
could be possibly accessed more eﬃciently when performed on
the automated and miniaturized ADE technology platform
(Figure 1A−F).
Thus, we ﬁrst performed and optimized the proposed
reaction and the subsequent acid-catalyzed cyclization/
oxidation reaction on a mg scale using 3,5-dimethoxybenzyl-
amine, 2,2-dimethoxyacetaldehyde, benzoic acid, and phenyl-
ethyl isocyanide. The best conditions for the cyclization were
methanol as the solvent for the Ugi reaction and 37% HCl(aq)
solution in dioxane (1:1, v/v) aﬀording the isoquinoline 3a in
68% yield (Scheme 1, Table S1). It is noteworthy that the
reaction runs under very mild conditions at room temperature.
To thoroughly investigate the substrate scope and
limitations in a rapid way, we envisioned using the nL-volume
ADE technology to build a random library of isoquinolines.33
Thus, we used 7 diﬀerent benzyl amines including heterocyclic
derivatives and 62 isocyanides as building blocks (Figure 2,
Figure S2). The theoretically possible combinations of
substrates can result in 434 diﬀerent isoquinolines. To
accelerate and facilitate synthesis and analytics, the preparation
of a random library of isoquinolines in a 384-well plate was
performed. The reactants were dissolved as 0.5 M ethylene
glycol stock solutions in a polypropylene (PP) source plate and
were dispensed via ADE into a PP 384-well destination plate
using an Echo 555 acoustic dispenser to yield 3000 nL ﬁnal
volume per well. Then, 375 nmol of each starting material (750
nL of 0.5 M stock solution) was transferred to the destination
plate which theoretically results in 375 nmol of product in the
case of 100% yield (page S5, Supporting Information).
Ethylene glycol was the solvent of choice with a low volatility
and otherwise similar properties to methanol, which is the
typical solvent for Ugi reactions. The total transfer time was
∼150 min. The sealed plate was shaken for 12 h when 10 μL of
37% HCl(aq)/dioxane solution (1:1, v/v) was added. The plate
was kept at room temperature for another 12 h. Then, the plate
was dried of the solvent by applying a mild stream of nitrogen.
Figure 1. Experimental workﬂow of nanochemistry and design of reaction. (A) Stock solution and source plate preparation with the required
building blocks. (B) Nanodroplet acoustic droplet ejection transfer with Echo 555 system. (C) Destination 384-well plate after compound transfer.
Analytics of the synthesis plate by (D) SFC-MS, and (E) TLC-MS. (F) Data analysis. (G) Classical isoquinoline syntheses and the newly designed
isoquinoline synthesis.
Scheme 1. Optimized Condition for Ugi/Schlittler−Müller Reaction
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The analytics of all wells was performed by two comple-
mentary methods, supercritical ﬂuid chromatography (SFC-
UV-MS) and thin-layer chromatography (TLC-UV-MS)
(Figure 3; page S13, Supporting Information). The SFC
analytic of one well takes ∼1 min, resulting in an overall
measuring time for the 384-well plate of less than one night
(page S13, Supporting Information).
A qualitative indication of the reaction performance was
obtained by analyzing the MS of the product in the SFC
(Figure 3A,B). Moreover, we were investigating all wells by
TLC-UV-MS as a complementary method (Figure 3C). The
TLC-UV-MS of all 384 wells was performed in less than 5 h.
Good agreement was found between the two diﬀerent
analytical methods. We found that the majority of the
reactions worked very well, and the main peak in the
chromatograms corresponded to the expected products.
More than 80% of the reactions gave the corresponding
products (Scheme S4). All electron-rich benzylamines (A1−6)
and the heterocyclic thiophene derivative A7 reacted similarly
well. The compatibility of the isocyanides was surprising. A
great diversity of not commonly used isocyanides reacted well,
including primary linear, bulky tertiary aliphatic, aromatic,
substituted benzylic, heterocyclic, and amino-acid-derived
isocyanides. Functional group compatibility involved halogens,
nitrile, ether, ketone, allyl, amide, ester, and acrylamide,
including several multifunctional derivatives. A total of 68
reactions failed (18%, red designation).
Figure 2. Building blocks used for the new isoquinoline synthesis.
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Out of 62 investigated isocyanides only 7 did not react at all
(11%, I47, I48, I52, I53, I55, I56, I60). We found that the two
morpholinoethyl-containing isocyanides (I53, I56) reacted
well in the Ugi reaction; however, no reaction was detected in
the following cyclization/oxidation step, even by repeating the
reaction on a mg scale. o-Azido benzylisocyanide (I47) also
did not react in all seven cases. Azido groups are known to be
unstable under highly acidic conditions and might decompose
under the cyclization conditions. Moreover, indole-containing
isocyanide (I48) did not show the expected mass of the
product. We speculate that the indole moiety under the highly
acidic conditions is undergoing secondary reactions such as
Pictet−Spengler-type reactions. All methyl ester substituted
isocyanides (I52, I55, I60) are designated red in the heat map
despite showing the product, however, as transesteriﬁcation
toward the glycol esters. Clearly, the ADE-enabled HTE gives
valuable insight into building block combination which
otherwise are not amenable in a reasonable time frame.
Figure 3. Chemical space accessed by ADE-enabled isoquinoline scouting. Exemplary analysis of well F2 by (A) SFC and (C) TLC-UV-MS. (B)
Heat map of a 384-well plate based on SFC-UV-MS analysis. In the mass chromatogram, if the peak corresponding to M+1 was the major peak, the
well was given a green designation, and otherwise yellow. If the peak of M+1 was absent, the well was given a red designation.
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Scalability of a reaction over several orders of scale is not
automatically given. Therefore, to demonstrate the scalability
of nmol-based results of the ADE technology, we scaled
randomly chosen reactions of the 384-well plate to multi-mg
scale (Figure 4, Figure S3). We resynthesized a library of 29
isoquinolines and heterocyclic derivatives in 26−73% isolated
yields by probing various electron-rich benzylamines, thio-
phene methylamine, and isocyanides. Among the resynthesized
compounds, 17 diﬀerent isocyanides and 6 diﬀerent benzyl
amines as starting material were reacted. For example, 3-
(isocyanomethyl)-tetrahydrofuran which led to interesting
product J3 with hydrophilic tetrahydrofuran side chain worked
well. The methylester containing products (J18, K5, and L7)
gave clean products in 35%, 33%, and 26% yields, respectively.
The introduction of the amino acid ester isocyanides can be
beneﬁcial for further modiﬁcations to synthesize diversiﬁed
scaﬀolds and more complex peptide mimetics. Moreover, the
thienopyridine scaﬀolds (A3, A13, K21, N15, O11, P8), which
are known for their anticancer and antiplatelet activities,34,35
were constructed with moderate to good yields (43−53%) in
just one step. The structures of several novel isoquinoline
products and thus novel reactions were conﬁrmed by X-ray
crystallography (Figure S5). To further underscore the
scalability of the new isoquinoline synthesis, we performed a
multigram 30 mmol synthesis of C2 (Figure 5, Figure S4).
Gratifyingly, the reaction product precipitated out (72% yield)
after overnight stirring of the Ugi-adduct under acidic
conditions. In addition, the obtained product was 89% pure
without any column chromatography, determined by quanti-
tative NMR (qNMR) using benzyl benzoate as internal
standard (pages S133 and S135, Supporting Information).
Thorough investigation of scope and limitation of a novel
reaction are a major challenge in contemporary synthetic
chemistry because many diﬀerent combinations of diﬀer-
entially substituted building blocks have to be reacted.6 It is,
however, of uttermost importance to be adopted by end-users.
Functional group tolerance of the reactions limits the scope of
structure−activity studies. Seemingly small local steric,
electronic, or stereoelectronic eﬀects imposed by diverse
functional groups in the starting materials often have dramatic
eﬀects on the outcome of the reaction.8,9,19 It is believed that
the major hurdle to the application of a new chemical
methodology to real synthetic problems is a lack of
information regarding its application beyond the idealized
conditions of the seminal report. Therefore, robustness
screens, e.g., for the rapid assessment of catalytic reactions
have been proposed which used diﬀerent equimolar additives
Figure 4. Structures and representative X-ray structures of the isoquinolines resynthesized on a mmol scale selected from the plate according to the
analytical performance.
Figure 5. Scalability: from μg-scale scouting to mg- and g-scale
synthesis.
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in the presence of a simple reaction to monitor their
interference.36 We herein pursued a diﬀerent path of reaction
scouting by randomly performing diﬀerent reactions based on
a real-world selection of multiple building blocks with many
diﬀerent functional groups potentially interfering with the
reaction at a miniaturized nmol scale. To exemplify this
technology, we have used automated ADE to scout a newly
designed isoquinoline synthesis. The miniaturized high-
throughput technique allows for the rapid synthesis of libraries
of compounds on a nmol scale. In less than 2 days, 384
reactions were performed including quality evaluation of each
reaction by SFC-MS and TLC-UV-MS. An unprecedented
large number of 62 substituted isocyanides were randomly
combined with 7 diﬀerent benzylamines to evaluate the
chemical reaction space. The great majority (∼80%) of the
nanoscale reactions revealed the product. Probing highly
substituted starting materials revealed a great functional group
compatibility including hydrophilic moieties. This is of high
importance to gain access to druglike properties, e.g., metabolic
stability and solubility in body liquids. Resynthesis of 29
examples on a traditional mmol scale was performed in good to
excellent yields, showing the scalability of the reaction.
Another example was synthesized on a ∼10 g scale. This
approach is in contrast to the classical reaction evaluation
where only a small number of derivatives are synthesized on a
mmol scale, in low-density reaction arrays, and little
information about the scope of a reaction is generated.
Advantages of the synthesis technology include not only fast
and fair assessment of the scope of a new reaction but also
overall very low material consumption. This allows the
inclusion of precious starting materials, e.g., the majority of
the isocyanides used. The total amount of building block
material used in the successful synthesis of >300 unprece-
dented isoquinolines is less than 50 mg.
Million-sized screening libraries of pharmaceutical compa-
nies are still built on mg amounts of puriﬁed compounds.
Therefore, periodical renewal of the library content is a
synthetic and logistic challenge. An application of the herein
described automated nanoscale ADE-enabled synthesis can be
envisioned to be a rapid and eﬃcient prescreen of the chemical
space of a novel reaction. With this, synthesizable compounds
may be rapidly identiﬁed at a nanomole-scale to select
compounds for mg scale-up including time-consuming reaction
puriﬁcation to ﬁll the screening decks of pharmaceutical and
agrochemical companies for the discovery of novel bioactive
compounds. Recent computer-assisted synthetic advancements
including artiﬁcial-intelligence-driven synthesis planning and
structure-based machine learning reactivity prediction describe
a pathway to automated and accelerated synthesis.37 However,
it remains a signiﬁcant challenge to devise automated wet-lab
synthesis without extensive and lengthy optimization.16
Synthetic organic chemistry with an almost inﬁnite number
of reactions and associated reaction conditions for now
remains a largely experimental science, which our technology
platform is well-positioned to accelerate.
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